Pelthos Therapeutics PTHS
NYSE PTHS
$9.34 +0.37 (+4.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Pelthos Therapeutics (PTHS) Cash from Investing Activities (2025 - 2026)

Updated

Pelthos Therapeutics' Cash from Investing Activities came in at -$2,000 for Q2 2026.

Analysis

Pelthos Therapeutics (PTHS) Cash from Investing Activities (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Pelthos Therapeutics reported Cash from Investing Activities of -$5.43 million; for FY2025, it came in at -$5.24 million.

  • The five-year range for quarterly Cash from Investing Activities is -$8 million (Q4 2025) to $2.76 million (Q3 2025).
  • Business Quant data shows PTHS's Cash from Investing Activities at -$194,000 (Q1 2026), -$8 million (Q4 2025) and $2.76 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -8.30 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -2.71 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -10.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -1.32 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.89 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -649.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -244.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -2.03 Bn
10 Pelthos Therapeutics 33.36 Mn -55.04 Mn 11.99 Mn -2,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,000.00
Mar 31, 2026 -194,000.00
Dec 31, 2025 -8.00 Mn
Sep 30, 2025 2.76 Mn
API Access

Pelthos Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=PTHS&period=max&api_key=YOUR_API_KEY